Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia.
Centenary Institute of Cancer Medicine & Cell Biology, University of Sydney, Camperdown, NSW, Australia.
Epigenomics. 2019 May;11(7):732-737. doi: 10.2217/epi-2018-0173. Epub 2019 May 9.
To investigate the integrated epigenetic regulation of acquired drug resistance in cancer. Our gene expression data of five induced drug-tolerant cell models, one resistant cell line and one publicly available drug-resistant dataset were integrated to identify common differentially expressed genes and pathways. ChIP-seq and DNA methylation by HM450K beadchip were used to study the epigenetic profile of differential expressed genes. Integrated transcriptomic analysis identified a common 'viral mimicry' related gene signature in induced drug-tolerant cells and the resistant state. Analysis of the epigenetic regulation revealed a common set of down-regulated genes, which are marked and regulated by a concomitant loss of H3K4me3, gain of H3K9me3 and increment of regional DNA methylation levels associated with tumor suppressor genes and apoptotic signaling.
研究获得性药物耐药性的综合表观遗传调控。我们整合了五个诱导耐药细胞模型、一个耐药细胞系和一个公开的耐药数据集的基因表达数据,以鉴定共同差异表达的基因和途径。使用 ChIP-seq 和 HM450K 珠芯片进行 DNA 甲基化研究差异表达基因的表观遗传特征。综合转录组分析在诱导耐药细胞和耐药状态中鉴定出一个共同的“病毒模拟”相关基因特征。表观遗传调控分析揭示了一组共同下调的基因,这些基因被标记并受 H3K4me3 的伴随丢失、H3K9me3 的获得以及与肿瘤抑制基因和凋亡信号相关的区域性 DNA 甲基化水平的增加调节。